The Ivy Brain Tumor Center at Barrow Neurological Institute, a non-profit translational research program that specializes in identifying new, first-in-class therapeutic agents that match the individual biologies of brain tumor patients, has announced the appointment of Benjamin Cravatt, Ph.D to its Scientific Advisory Board.
June 26, 2020
· 2 min read